Q1 FY27 results: PAT up 64% YoY, promoter to invest via warrants

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹1.88

prior close

₹1.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.7% vs market

Non Banking Financial Company (NBFC) peers, median of 214sector-0.5%+1.5% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.5 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.1

15m

+0.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.4+0.7-0.5+1.5

Next day

+0.0+0.5-0.5+0.0+0.0

-0.5+0.6-1.1-0.2-0.3

+0.5+0.7-0.2-0.8+1.3

+0.0+1.1-1.1-1.1+1.1

+1.1+0.5+0.5-1.8+2.9

+1.1+1.3-0.2-0.7+1.7

15d

-1.1+0.5-1.6-1.9+0.8

-3.7-0.8-2.9-3.0-0.8

-14.4-0.9-13.4-3.8-10.6

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 214Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anupam Finserv's Q1 FY27 profit after tax rose to Rs 56.15 lakh, up about 64% YoY from Rs 34.26 lakh. Total income grew 48% to Rs 1.72 crore versus Rs 1.16 crore a year ago. Board also approved issuing 40 lakh convertible warrants at Rs 1.92 each to promoter Pravin Gala, aggregating Rs 76.80 lakh, raising his stake from 21.75% to 23.37%. Auditor CGCA and Associates LLP issued a clean limited review report with no qualifications.

Likely market impact

Strong Q1 growth signals business momentum. Promoter warrant infusion shows confidence but adds minor dilution risk; track conversion within 18 months.